Total Payments
$4,122
2024 Payments
$646.61
Companies
19
Transactions
131
Medicare Patients
2,729
Medicare Billing
$335,697
Payment Breakdown by Category
Food & Beverage$3,290 (79.8%)
Travel$751.97 (18.2%)
Education$80.99 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,290 | 124 | 79.8% |
| Travel and Lodging | $751.97 | 5 | 18.2% |
| Education | $80.99 | 2 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,143 | 12 | $0 (2024) |
| Medtronic, Inc. | $574.84 | 16 | $0 (2024) |
| Abbott Laboratories | $518.07 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $462.97 | 19 | $0 (2024) |
| PFIZER INC. | $221.85 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $183.48 | 12 | $0 (2024) |
| Boston Scientific Corporation | $163.43 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $146.67 | 10 | $0 (2024) |
| ABIOMED | $130.29 | 1 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $120.88 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $646.61 | 21 | AstraZeneca Pharmaceuticals LP ($163.08) |
| 2023 | $393.26 | 21 | AstraZeneca Pharmaceuticals LP ($155.57) |
| 2022 | $847.96 | 27 | Medtronic, Inc. ($292.74) |
| 2021 | $1,528 | 25 | Edwards Lifesciences Corporation ($1,007) |
| 2020 | $242.47 | 10 | PFIZER INC. ($184.14) |
| 2019 | $328.91 | 18 | Janssen Pharmaceuticals, Inc ($88.75) |
| 2018 | $135.53 | 9 | Regeneron Healthcare Solutions, Inc. ($45.00) |
All Payment Transactions
131 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Renal Denervation System | ||||||
| 12/05/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $29.50 | General |
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| Category: Cardiovascular | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Renal Denervation System | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Obesity | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.75 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Renal Denervation System | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $63.74 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: Cardiovascular | ||||||
| 04/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Transcatheter Valve Systems | ||||||
| 02/20/2024 | Abbott Laboratories | NAVITOR (Device) | Food and Beverage | In-kind items and services | $153.27 | General |
| Category: Vascular | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/09/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $101.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Heart Failure | ||||||
| 11/10/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Stents | ||||||
| 10/31/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,021 | 2,739 | $855,132 | $239,875 |
| 2022 | 15 | 708 | 1,044 | $343,132 | $95,822 |
Total Patients
2,729
Total Services
3,783
Medicare Billing
$335,697
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 282 | 718 | $156,524 | $68,757 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 279 | 312 | $134,472 | $43,059 | 32.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 446 | 454 | $123,250 | $23,600 | 19.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 179 | 331 | $49,981 | $21,365 | 42.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 59 | 111 | $34,077 | $15,670 | 46.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 71 | 71 | $132,912 | $15,119 | 11.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 25 | 27 | $48,060 | $13,242 | 27.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 81 | 85 | $25,075 | $8,970 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 68 | $15,572 | $6,816 | 43.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 28 | 28 | $26,320 | $4,233 | 16.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 55 | 55 | $14,245 | $3,246 | 22.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $7,088 | $2,901 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,821 | $2,527 | 37.0% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 21 | 22 | $11,198 | $1,753 | 15.7% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $16,885 | $1,695 | 10.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $9,979 | $1,454 | 14.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 122 | 128 | $20,864 | $1,347 | 6.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 66 | 66 | $4,026 | $1,049 | 26.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 41 | 43 | $3,225 | $821.78 | 25.5% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 13 | 13 | $6,656 | $756.63 | 11.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 66 | 66 | $2,706 | $705.20 | 26.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 45 | $3,240 | $531.96 | 16.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 15 | 15 | $1,560 | $213.15 | 13.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 18 | 18 | $396.00 | $43.73 | 11.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 133 | 371 | $80,878 | $31,421 | 38.9% |
About Dr. Abdulrahman Dia, MD
Dr. Abdulrahman Dia, MD is a Interventional Cardiology healthcare provider based in Oak Lawn, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2014. The National Provider Identifier (NPI) number assigned to this provider is 1801209671.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdulrahman Dia, MD has received a total of $4,122 in payments from pharmaceutical and medical device companies, with $646.61 received in 2024. These payments were reported across 131 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,290).
As a Medicare-enrolled provider, Dia has provided services to 2,729 Medicare beneficiaries, totaling 3,783 services with total Medicare billing of $335,697. Data is available for 2 years (2022–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Oak Lawn, IL
- Active Since 06/09/2014
- Last Updated 01/06/2026
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1801209671
Products in Payments
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $771.39
- COREVALVE EVOLUT R (Device) $277.15
- ELIQUIS (Drug) $271.41
- BRILINTA (Drug) $227.35
- NAVITOR (Device) $153.27
- CoreValve Evolut (Device) $150.04
- XARELTO (Drug) $146.67
- AMPLATZER (Device) $136.74
- WAINUA (Drug) $132.32
- Impella (Device) $130.29
- LifeVest (Device) $120.88
- ENTRESTO (Drug) $116.96
- FARXIGA (Drug) $103.30
- ONYX FRONTIER (Device) $85.62
- CVI Systems (Device) $83.00
- CardioMEMS HF System (Device) $76.55
- LEQVIO (Drug) $66.52
- SAPIEN 3 Ultra RESILIA (Device) $63.74
- SYMPLICITY G3 (Device) $62.03
- Repatha (Biological) $57.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Oak Lawn
Dr. Surendra Avula, Md, MD
Interventional Cardiology — Payments: $119,931
Interventional Cardiology $119,931
Dr. Paul Silverman, Md,Facc, MD,FACC
Interventional Cardiology — Payments: $23,792
Interventional Cardiology $23,792
Dr. Ali Kutom, M.d, M.D
Interventional Cardiology — Payments: $9,823
Interventional Cardiology $9,823
Adham Karim, Md, MD
Interventional Cardiology — Payments: $9,484
Interventional Cardiology $9,484
Dr. Sheraz Hussain, Md, MD
Interventional Cardiology — Payments: $825.25
Interventional Cardiology $825.25